Kraig Biocraft Laboratories, Inc.
KBLB
$0.14
$0.001.05%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.21M | 3.21M | 2.18M | 3.05M | 2.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.37M | 3.37M | 2.36M | 3.21M | 3.07M |
| Operating Income | -3.37M | -3.37M | -2.36M | -3.21M | -3.07M |
| Income Before Tax | -3.62M | -3.69M | -2.61M | -3.49M | -3.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.62 | -3.69 | -2.61 | -3.49 | -3.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.62M | -3.69M | -2.61M | -3.49M | -3.40M |
| EBIT | -3.37M | -3.37M | -2.36M | -3.21M | -3.07M |
| EBITDA | -3.35M | -3.34M | -2.33M | -3.18M | -3.05M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 4.24B | 4.20B | 4.17B | 4.16B | 4.15B |
| Average Diluted Shares Outstanding | 4.24B | 4.20B | 4.17B | 4.16B | 4.15B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |